Technology area: Chemistry & Materials
3 pending office actions • 2 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready
Godo Shusei Co. Ltd. currently manages 3 pending office actions in the Chemistry & Materials technology area. These cases are being reviewed by 3 distinct examiners across 2 distinct art units. This distribution shows that while the company's technology is concentrated in chemistry, it is being evaluated by several different individuals.
KANE, TREVOR LOGAN is the busiest examiner for the company, managing 1 pending office action. Since there are 3 pending office actions and 3 distinct examiners, the workload is distributed with 1 case per examiner. This allows the company to receive feedback from 3 different perspectives within the 2 distinct art units involved.
The presence of 2 distinct art units indicates that the company's filings in Chemistry & Materials fall into two separate technical categories. With 3 pending office actions, the company maintains a steady volume of prosecution activity. This profile reflects a portfolio with multiple active threads in the Chemistry & Materials sector.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KANE, TREVOR LOGAN | 1 | 69.4% | +52.5% |
| KERSHAW, KELLY P | 1 | 17.7% | +16.0% |
| GILLETT, JENNIFER ANN | 1 | 29.6% | +37.7% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18291003 | ENZYME-CONTAINING COMPOSITION, METHOD FOR PRODUCING MILK AND METHOD FOR PRODUCING FERMENTED MILK | KERSHAW, KELLY P | 18d overdue |
| 18689596 | LACTASE, LACTASE PREPARATION, GENE, RECOMBINANT VECTOR, AND TRANSFORMANT | KANE, TREVOR LOGAN | — |
| 17996278 | PACKAGED LACTASE SOLUTION | GILLETT, JENNIFER ANN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18291003 | ENZYME-CONTAINING COMPOSITION, METHOD FOR PRODUCING MILK AND METHOD FOR PRODUCING FERMENTED MILK | KERSHAW, KELLY P | 18d overdue |
| 18689596 | LACTASE, LACTASE PREPARATION, GENE, RECOMBINANT VECTOR, AND TRANSFORMANT | KANE, TREVOR LOGAN | — |
| 17996278 | PACKAGED LACTASE SOLUTION | GILLETT, JENNIFER ANN | — |
| Art Unit | Apps |
|---|---|
| 1791 | 2 |
| 1789 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18689596 | LACTASE, LACTASE PREPARATION, GENE, RECOMBINANT VECTOR, AND TRANSFORMANT | KANE, TREVOR LOGAN | 1791 | §103§112 | Non-Final OA | — | Pending | Mar 06, 2024 |
| 18291003 | ENZYME-CONTAINING COMPOSITION, METHOD FOR PRODUCING MILK AND METHOD FOR PRODUCING FERMENTED MILK | KERSHAW, KELLY P | 1791 | §103 | Final Rejection | 18d overdue | Pending | Jan 22, 2024 |
| 17996278 | PACKAGED LACTASE SOLUTION | GILLETT, JENNIFER ANN | 1789 | §102§103 | Final Rejection | — | Pending | Oct 14, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial